Literature DB >> 21960838

Preventing hepatitis B viral reactivation in patients receiving cancer chemotherapy.

Arie Regev1.   

Abstract

Entities:  

Year:  2007        PMID： 21960838      PMCID： PMC3099273     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Occult hepatitis B and infliximab-induced HBV reactivation.

Authors:  Salvatore Madonia; Ambrogio Orlando; Daniela Scimeca; Mirko Olivo; Francesca Rossi; Mario Cottone
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

2.  Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.

Authors:  S E Moses; Z Y Lim; M Sudhanva; S Devereux; A Y L Ho; A Pagliuca; M Zuckerman; G J Mufti
Journal:  J Med Virol       Date:  2006-12       Impact factor: 2.327

Review 3.  Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Authors:  H E Kohrt; D L Ouyang; E B Keeffe
Journal:  Aliment Pharmacol Ther       Date:  2006-10-01       Impact factor: 8.171

Review 4.  Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.

Authors:  Gadi Lalazar; Deborah Rund; Daniel Shouval
Journal:  Br J Haematol       Date:  2007-03       Impact factor: 6.998

Review 5.  Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention.

Authors:  Ayse L Mindikoglu; Arie Regev; Eugene R Schiff
Journal:  Clin Gastroenterol Hepatol       Date:  2006-07-24       Impact factor: 11.382
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.